Zimmer Biomet Holdings Inc (NYSE:ZBH)
$ 121.31 -0.13 (-0.11%) Market Cap: 24.96 Bil Enterprise Value: 30.52 Bil PE Ratio: 26.26 PB Ratio: 1.98 GF Score: 83/100

Zimmer Biomet Holdings Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript

Sep 15, 2020 / 06:00PM GMT
Release Date Price: $139.99 (+2.64%)
David Ryan Lewis
Morgan Stanley, Research Division - MD

Good afternoon, everyone. Coming to you live from the Morgan Stanley Healthcare Conference Year 2020. My name is David Lewis, medical device analyst at Morgan Stanley. And thanks for joining us here as we progress through the afternoon. It's our pleasure to have with us here members of management of Zimmer Biomet, both Bryan Hanson, CEO; and Suky Upadhyay, the CFO; and Keri is here as well. We're going to jump right into Q&A.

Questions & Answers

David Ryan Lewis
Morgan Stanley, Research Division - MD

Bryan, I think we're going to dispense with the preamble. And I want to start, Bryan, just on recovery here with COVID-19. We had a pretty bullish intraquarter here post the second quarter.

Just want to kind of talk about a little bit about what has happened from a trend line perspective here in July, August and into September?

Bryan C. Hanson
Zimmer Biomet Holdings, Inc. - President, CEO & Director

Yes. So can you hear me okay?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot